Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG: 1349)

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Market Cap

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. has a market cap or net worth of 7.11 billion as of November 22, 2024. Its market cap has decreased by -15.20% in one year.

• Market Cap: 7.11B
• Enterprise Value: 5.97B
• Revenue: 766.06M
• Ranking: n/a
• PE Ratio: 23.79
• Stock Price: 2.53

Market Cap Chart

Since August 13, 2002, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.'s market cap has increased from 582.40M to 7.11B, an increase of 1,120.50%. That is a compound annual growth rate of 11.88%.

Market Cap History

Date	Market Cap	% Change
Nov 22, 2024	7.11B	-11.71%
Dec 29, 2023	8.06B	3.73%
Dec 30, 2022	7.77B	-42.18%
Dec 31, 2021	13.43B	-14.60%
Dec 31, 2020	15.73B	282.12%
Dec 31, 2019	4.12B	14.07%